Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Mar 10;13:861525. doi: 10.3389/fimmu.2022.861525

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Guo, Yang, Ren, Tian, Gao, Tian, Zhang and Kan

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

The role of the ICI score in the prediction of immunotherapeutic benefits. (A) Kaplan–Meier curves for patients with high and low ICI score in the TGCA-LIHC cohort. (B) Comparison of the ICI score in response and non-response to immunotherapy in the TGCA-LIHC cohort. (C) Percentage of objective response rate to immunotherapy for high score and low score groups in the TGCA-LIHC cohort. (D) Kaplan–Meier curves for patients with high and low ICI scores in the GSE76427 cohort. (E) Comparison of ICI scores in response and non-response to immunotherapy in the GSE76427 cohort. (F) Percentage of objective response rate to immunotherapy for the high score and low score groups in the GSE76427 cohort. (G) Percentage of clinical parameters for high score and low score groups. (H) Comparison of clinical parameters between high score and low score groups.